Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $93.62M.
ENTERPRISE VALUE (EV)
$93.62M
LENZ Therapeutics, Inc.
Market Cap
$118.80M
Enterprise Value (EV)
$93.62M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $118.80M | $93.62M |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $118.02M | $102.89M |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.53M | $117.99M |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.00M | $120.41M |
| Genelux Corporation (GNLX)vs › | $116.36M | $109.60M |
| Coya Therapeutics, Inc. (COYA)vs › | $116.00M | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.99M | $107.49M |
| Cibus, Inc. (CBUS)vs › | $122.13M | $134.44M |
| enGene Holdings Inc. (ENGN)vs › | $122.59M | $114.84M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $114.74M | $89.76M |
Market Cap
$118.80M
Total Debt
$0.00
Cash
$25.18M
Enterprise Value
$93.62M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
